Quan Zheng - Publications

PHGDH: a metabolic switch in tumor drug resistance and a therapeutic target.

Journal: Drug discovery today

Published: November 23, 2025

FabH (β-Ketoacyl-ACP Synthase III) -- Promising Novel Antibacterial Target and Its Inhibitors.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Published: October 26, 2025

Sex-specific aging clocks from a large-scale human phenome reveal distinct aging transitions and circulating signatures.

Journal: Nature aging

Published: October 23, 2025

PHGDH as a therapeutic node: Natural modulators from TCM, degradation pathways, and emerging TPD strategies.

Journal: Pharmacological research

Published: October 04, 2025

Small molecule inhibitors of the co-receptor neuropilin-1.

Journal: Drug discovery today

Published: September 06, 2025

Research progress of drugs targeting GPC3 in cancer therapy.

Journal: Bioorganic chemistry

Published: September 06, 2025

Research progress of TRK inhibitors and their structure-activity relationship.

Journal: European journal of medicinal chemistry

Published: July 31, 2025

Multimodal clocks of human aging.

Journal: Cell

Published: May 19, 2025

Efficacy of sildenafil combined with statins in treating pulmonary hypertension secondary to chronic obstructive pulmonary disease.

Journal: Pathology, research and practice

Published: March 31, 2025

Human immune aging clock identifies RUNX1 as a decelerator of T cell senescence.

Journal: Immunity

Published: March 27, 2025

Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors.

Journal: Biochemical pharmacology

Published: February 16, 2025

Targeting FLT3 for treating diseases: FLT3 inhibitors.

Journal: Drug discovery today

Published: September 28, 2024